Sep. 10 at 8:04 PM
$AEO UBS raised its 2026 sales growth outlook by 120 basis points but cut 2027-2028 EPS estimates by 5%-6% as it reverses the non-recurring tariff refund benefit and flow through its assumptions for lower AE growth and higher SG&A into the outer years.
UBS maintained the company's buy rating price target to
$27 🎯